Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:
Schedule
Product: Blink Intensive Tears Protective Eye Drops (Unit Dose)
Active Ingredient: Macrogol 400 2.5mg/mL
Dosage Form: Solution
New Zealand Sponsor: Advanced Medical Optics Australia Pty Limited t/a Advanced Medical Optics NZ
Manufacturer: AMO Manufacturing Spain SL, Alcobendas, Madrid, Spain
Product: Blink Intensive Tears Protective Eye Drops (Multi Dose)
Active Ingredient: Macrogol 400 2.5mg/mL
Dosage Form: Solution
New Zealand Sponsor: Advanced Medical Optics Australia Pty Limited t/a Advanced Medical Optics NZ
Manufacturer: Advanced Medical Optics (Hangzhou) Co Limited, Hangzhou, Zhejiang, China
Product: Flamazine (Prescription)
Active Ingredient: Sulfadiazine silver 1%w/w
Dosage Form: Topical cream
New Zealand Sponsor: Smith & Nephew Limited (NZ)
Manufacturer: Solvay Pharma SA, Santiago Ramon y Cajal, Parets Del Valles, Barcelona, Spain
Product: Flamazine (Pharmacy Only)
Active Ingredient: Sulfadiazine silver 1%w/w
Dosage Form: Topical cream
New Zealand Sponsor: Smith & Nephew Limited (NZ)
Manufacturer: Solvay Pharma SA, Santiago Ramon y Cajal, Parets Del Valles, Barcelona, Spain
Product: Oxaliplatin
Active Ingredient: Oxaliplatin 100mg
Dosage Form: Powder for infusion
New Zealand Sponsor: REX Medical Limited
Manufacturer: Cipla Limited, Manufacturing Division, Verna, Salcette, Goa, India
Dated this 22nd day of October 2009.
MARK RICHARDS, Acting Deputy Director-General, Sector Accountability and Funding Directorate, Ministry of Health (pursuant to delegation given by the Minister of Health on 6 July 2001).